AVROBIO logo
AVROBIO AVRO

Quarterly report 2025-Q3
added 11-06-2025

report update icon

AVROBIO Market Cap 2011-2025 | AVRO

As of December 15, 2025 AVROBIO has a market cap of $ 745 M


Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]

Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.

This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.

Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.

Annual Market Cap AVROBIO

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
56.3 M 54.7 M 62.1 K 522 M 566 M 174 M - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
566 M 62.1 K 229 M

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.

Market Cap of other stocks in the Biotechnology industry

Issuer Market Cap Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
315 M - 2.43 % $ 254 M germanyGermany
AlloVir AlloVir
ALVR
49 M - 4.14 % $ 49.1 M usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
33.6 B - - $ 40.3 B usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
7.37 B $ 220.27 4.81 % $ 5 B danmarkDanmark
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
3.16 B $ 0.28 -2.28 % $ 609 M israelIsrael
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
895 M $ 3.3 -3.51 % $ 7.94 B australiaAustralia
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
28.9 M - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
79 M - -18.52 % $ 27.3 M britainBritain
Aptorum Group Limited Aptorum Group Limited
APM
4.09 M $ 1.29 -3.01 % $ 7.03 M chinaChina
Biophytis SA Biophytis SA
BPTS
549 M - -13.47 % $ 169 M franceFrance
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
2.83 B - - - russiaRussia
ARCA biopharma ARCA biopharma
ABIO
484 M - 1052.0 % $ 415 M usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
445 M $ 4.75 1.61 % $ 788 M canadaCanada
Aclaris Therapeutics Aclaris Therapeutics
ACRS
152 M $ 3.26 -3.12 % $ 252 M usaUSA
Acasti Pharma Acasti Pharma
ACST
40.7 M - 4.01 % $ 150 M canadaCanada
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
2.05 B - -15.15 % $ 60.3 M britainBritain
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
724 M - - $ 1.01 B usaUSA
Albireo Pharma Albireo Pharma
ALBO
538 M - -0.23 % $ 916 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
269 M - - $ 2.17 B usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
664 K - -11.43 % $ 502 K usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
1.31 B $ 25.27 -2.43 % $ 1.22 B usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
22.1 M - - $ 10.1 M usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
373 M $ 9.57 0.84 % $ 140 M usaUSA
BioNTech SE BioNTech SE
BNTX
62.9 B $ 94.73 -1.32 % $ 27.2 B germanyGermany
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
5.65 B - -6.81 % $ 3.04 B usaUSA
Athersys Athersys
ATHX
364 M - 3.77 % $ 22.4 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
12.1 M - 2.71 % $ 14 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
544 K - -52.27 % $ 4.45 M usaUSA
Axon Enterprise Axon Enterprise
AXON
39.8 B $ 566.18 -2.56 % $ 42.9 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.72 M - - $ 7.46 M israelIsrael
Aytu BioScience Aytu BioScience
AYTU
15.8 M $ 2.34 2.59 % $ 14.7 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
81.2 B $ 89.78 -0.57 % $ 96.9 B britainBritain
Acorda Therapeutics Acorda Therapeutics
ACOR
16.7 M - -24.86 % $ 820 K usaUSA
Brickell Biotech Brickell Biotech
BBI
11.4 M - -5.38 % $ 6.06 M usaUSA
Burford Capital Limited Burford Capital Limited
BUR
2.09 B $ 9.09 -0.55 % $ 1.5 B britainBritain
BeiGene, Ltd. BeiGene, Ltd.
BGNE
253 B - 0.49 % $ 251 B cayman-islandsCayman-islands
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
8.59 B $ 11.54 0.87 % $ 746 M usaUSA
Biogen Biogen
BIIB
19.3 B $ 174.42 1.11 % $ 25.4 B usaUSA
BioVie BioVie
BIVI
2.44 M $ 1.42 -5.96 % $ 2.1 M usaUSA
Abeona Therapeutics Abeona Therapeutics
ABEO
149 M $ 5.36 -2.99 % $ 115 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
1.73 B $ 10.85 -0.14 % $ 1.41 B usaUSA
ADiTx Therapeutics ADiTx Therapeutics
ADTX
59.2 K $ 2.3 -3.0 % $ 30.3 K usaUSA
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
8.32 M - -9.72 % $ 5.89 M usaUSA
Berkeley Lights Berkeley Lights
BLI
117 M - -7.31 % $ 87 M usaUSA
Advaxis Advaxis
ADXS
1.87 M - -9.65 % $ 45.9 M usaUSA
Завод ДИОД Завод ДИОД
DIOD
661 M - - - russiaRussia
Фармсинтез Фармсинтез
LIFE
2 B - - - russiaRussia
BioLineRx Ltd. BioLineRx Ltd.
BLRX
1.35 B $ 3.17 -1.86 % $ 908 M israelIsrael
bluebird bio bluebird bio
BLUE
67 M - - $ 546 M usaUSA